Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1 Free

Abstract

West Nile virus (WNV) non-structural protein 1 (NS1) elicits protective immune responses during infection of animals. WNV NS1-specific antibody responses can provide the basis for serological diagnostic reagents, so the antigenic sites in NS1 that are targeted by host immune responses need to be identified and the conservation of these sites among the Japanese encephalitis virus (JEV) serocomplex members also needs to be defined. The present study describes the mapping of linear B-cell epitopes in WNV NS1. We screened eight NS1-specific mAbs and antisera (polyclonal antibodies; pAbs) from mice immunized with recombinant NS1 for reactivity against 35 partially overlapping peptides covering the entire WNV NS1. The screen using mAbs identified four WNV-specific (including Kunjin virus) epitopes, located at aa 21–36, 101–116, 191–206 and 261–276 in WNV NS1. However, using pAbs, only three WNV-specific epitopes were identified, located at positions 101–116, 191–206 and 231–246. Two of these epitopes (aa 21–36 and 261–276) had different reactivity with mAbs and pAbs. The knowledge and reagents generated in this study have potential applications in differential diagnostics and epitope-based marker vaccine development for WNV and viruses of the JEV serocomplex.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.034900-0
2012-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/1/50.html?itemId=/content/journal/jgv/10.1099/vir.0.034900-0&mimeType=html&fmt=ahah

References

  1. Amorim J. H., Porchia B. F., Balan A., Cavalcante R. C., da Costa S. M., de Barcelos Alves A. M., de Souza Ferreira L. C. 2010; Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein. J Virol Methods 167:186–192 [View Article][PubMed]
    [Google Scholar]
  2. Chambers T. J., Hahn C. S., Galler R., Rice C. M. 1990; Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649–688 [View Article][PubMed]
    [Google Scholar]
  3. Chen Y., Pan Y., Guo Y., Qiu L., Ding X., Che X. 2010; Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. Virology 398:290–298 [View Article][PubMed]
    [Google Scholar]
  4. Chung K. M., Liszewski M. K., Nybakken G., Davis A. E., Townsend R. R., Fremont D. H., Atkinson J. P., Diamond M. S. 2006a; West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A 103:19111–19116 [View Article][PubMed]
    [Google Scholar]
  5. Chung K. M., Nybakken G. E., Thompson B. S., Engle M. J., Marri A., Fremont D. H., Diamond M. S. 2006b; Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms. J Virol 80:1340–1351 [View Article][PubMed]
    [Google Scholar]
  6. Costa S. M., Freire M. S., Alves A. M. 2006; DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine 24:4562–4564 [View Article][PubMed]
    [Google Scholar]
  7. Costa S. M., Azevedo A. S., Paes M. V., Sarges F. S., Freire M. S., Alves A. M. 2007; DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358:413–423 [View Article][PubMed]
    [Google Scholar]
  8. Denisova G. F., Denisov D. A., Yeung J., Loeb M. B., Diamond M. S., Bramson J. L. 2008; A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein. Mol Immunol 46:125–134 [View Article][PubMed]
    [Google Scholar]
  9. Garmendia A. E., Van Kruiningen H. J., French R. A. 2001; The West Nile virus: its recent emergence in North America. Microbes Infect 3:223–229 [View Article][PubMed]
    [Google Scholar]
  10. Heinz F. X., Collett M. S., Purcell R. H., Gould E. A., Howard C. R., Houghton M., Moormann R. J. M., Rice C. M., Thiel H.-J. 2000; Family Flaviviridae. In Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses pp. 859–878 Edited by van Regenmortel M. H. V., Fauquet C. M., Bishop D. H. L., Carstens E. B., Estes M. K., Lemon S. M., Maniloff J., Mayo M. A., McGeoch D. J. et al. San Diego, CA: Academic Press;
    [Google Scholar]
  11. Huang J. H., Wey J. J., Sun Y. C., Chin C., Chien L. J., Wu Y. C. 1999; Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever. J Med Virol 57:1–8 [View Article][PubMed]
    [Google Scholar]
  12. Jan L. R., Yang C. S., Trent D. W., Falgout B., Lai C. J. 1995; Processing of Japanese encephalitis virus non-structural proteins: NS2B–NS3 complex and heterologous proteases. J Gen Virol 76:573–580 [View Article][PubMed]
    [Google Scholar]
  13. Jiang L., Zhou J. M., Yin Y., Fang D. Y., Tang Y. X., Jiang L. F. 2010; Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Virus Res 150:49–55 [View Article][PubMed]
    [Google Scholar]
  14. Kanai R., Kar K., Anthony K., Gould L. H., Ledizet M., Fikrig E., Marasco W. A., Koski R. A., Modis Y. 2006; Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80:11000–11008 [View Article][PubMed]
    [Google Scholar]
  15. Kitai Y., Shoda M., Kondo T., Konishi E. 2007; Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera. Clin Vaccine Immunol 14:1024–1031 [View Article][PubMed]
    [Google Scholar]
  16. Köhler G., Milstein C. 1975; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497 [View Article][PubMed]
    [Google Scholar]
  17. Konishi E., Fujii A., Mason P. W. 2001; Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol 75:2204–2212 [View Article][PubMed]
    [Google Scholar]
  18. Koraka P., Zeller H., Niedrig M., Osterhaus A. D., Groen J. 2002; Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 4:1209–1215 [View Article][PubMed]
    [Google Scholar]
  19. Kuno G. 2003; Serodiagnosis of flaviviral infections and vaccinations in humans. Adv Virus Res 61:3–65 [View Article][PubMed]
    [Google Scholar]
  20. Levy R., Forsyth C. M., LaPorte S. L., Geren I. N., Smith L. A., Marks J. D. 2007; Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol 365:196–210 [View Article][PubMed]
    [Google Scholar]
  21. Lin Y. L., Chen L. K., Liao C. L., Yeh C. T., Ma S. H., Chen J. L., Huang Y. L., Chen S. S., Chiang H. Y. 1998; DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72:191–200[PubMed]
    [Google Scholar]
  22. Lin C. W., Liu K. T., Huang H. D., Chen W. J. 2008; Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 30:205–214 [View Article][PubMed]
    [Google Scholar]
  23. Lindenbach B. D., Rice C. M. 1997; trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 71:9608–9617[PubMed]
    [Google Scholar]
  24. Mason P. W. 1989; Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 169:354–364 [View Article][PubMed]
    [Google Scholar]
  25. May C., Doody J. F., Abdullah R., Balderes P., Xu X., Chen C. P., Zhu Z., Shapiro L., Kussie P. other authors 2005; Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105:4337–4344 [View Article][PubMed]
    [Google Scholar]
  26. McLean R. G., Ubico S. R., Bourne D., Komar N. 2002; West Nile virus in livestock and wildlife. Curr Top Microbiol Immunol 267:271–308 [View Article][PubMed]
    [Google Scholar]
  27. Oliphant T., Nybakken G. E., Engle M., Xu Q., Nelson C. A., Sukupolvi-Petty S., Marri A., Lachmi B.-E., Olshevsky U. other authors 2006; Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 80:12149–12159 [View Article][PubMed]
    [Google Scholar]
  28. Shen X., Parks R. J., Montefiori D. C., Kirchherr J. L., Keele B. F., Decker J. M., Blattner W. A., Gao F., Weinhold K. J. other authors 2009; In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J Virol 83:3617–3625 [View Article][PubMed]
    [Google Scholar]
  29. Shi P. Y., Wong S. J. 2003; Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn 3:733–741 [View Article][PubMed]
    [Google Scholar]
  30. Sotelo E., Fernandez-Pinero J., Llorente F., Agüero M., Hoefle U., Blanco J. M., Jiménez-Clavero M. A. 2009; Characterization of West Nile virus isolates from Spain: new insights into the distinct West Nile virus eco-epidemiology in the Western Mediterranean. Virology 395:289–297 [View Article][PubMed]
    [Google Scholar]
  31. Sukupolvi-Petty S., Austin S. K., Engle M., Brien J. D., Dowd K. A., Williams K. L., Johnson S., Rico-Hesse R., Harris E. other authors 2010; Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 84:9227–9239 [View Article][PubMed]
    [Google Scholar]
  32. Sun E. C., Zhao J., Yang T., Liu N. H., Geng H. W., Qin Y. L., Wang L. F., Bu Z. G., Yang Y. H. other authors 2011; Identification of a conserved JEV serocomplex B-cell epitope by screening a phage-display peptide library with a mAb generated against West Nile virus capsid protein. Virol J 8:100 [View Article][PubMed]
    [Google Scholar]
  33. Volpina O. M., Volkova T. D., Koroev D. O., Ivanov V. T., Ozherelkov S. V., Khoretonenko M. V., Vorovitch M. F., Stephenson J. R., Timofeev A. V. 2005; A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Virus Res 112:95–99 [View Article][PubMed]
    [Google Scholar]
  34. Wang B., Hua R. H., Tian Z. J., Chen N. S., Zhao F. R., Liu T. Q., Wang Y. F., Tong G. Z. 2009; Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus. Virus Res 141:90–95 [View Article][PubMed]
    [Google Scholar]
  35. Weissenböck H., Kolodziejek J., Url A., Lussy H., Rebel-Bauder B., Nowotny N. 2002; Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerg Infect Dis 8:652–656[PubMed] [CrossRef]
    [Google Scholar]
  36. Williams D. T., Daniels P. W., Lunt R. A., Wang L. F., Newberry K. M., Mackenzie J. S. 2001; Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses. Am J Trop Med Hyg 65:379–387[PubMed]
    [Google Scholar]
  37. Wu H. C., Huang Y. L., Chao T. T., Jan J. T., Huang J. L., Chiang H. Y., King C. C., Shaio M. F. 2001; Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol 39:977–982 [View Article][PubMed]
    [Google Scholar]
  38. Xu G., Xu X., Li Z., He Q., Wu B., Sun S., Chen H. 2004; Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 22:1846–1853 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.034900-0
Loading
/content/journal/jgv/10.1099/vir.0.034900-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed